Myleran

Product manufactured by Aspen Global Inc.

Application Nr Approved Date Route Status External Links
NDA009386 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Myleran (Busulfan) Is Indicated For The Palliative Treatment Of Chronic Myelogenous (Myeloid, Myelocytic, Granulocytic) Leukemia.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Busulfan BUSULFAN ZINC1530572

Comments